1 2 3 4 5

Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda

Mutimura, Eugene; Addison, Diane; Anastos, Kathryn; More

AIDS . 29(1):67-76, January 2, 2015.

Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in HIV-infected women

Frasco, Melissa A.; Karim, Roksana; Van Den Berg, David; More

AIDS . 28(12):1815-1823, July 31, 2014.

HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients

Landay, Alan; Golub, Elizabeth T.; Desai, Seema; More

AIDS . 28(5):739-743, March 13, 2014.

Common clinical conditions – age, low BMI, ritonavir use, mild renal impairment – affect tenofovir pharmacokinetics in a large cohort of HIV-infected women

Baxi, Sanjiv M.; Greenblatt, Ruth M.; Bacchetti, Peter; More

AIDS . 28(1):59-66, January 2, 2014.

Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States

Murphy, Kerry; Hoover, Donald R.; Shi, Qiuhu; More

AIDS . 27(15):2413-2423, September 24, 2013.

Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women

Driver, Todd H.; Scherzer, Rebecca; Peralta, Carmen A.; More

AIDS . 27(14):2291-2299, September 10, 2013.

HIV serostatus differs by catechol-O-methyltransferase Val158Met genotype

Sundermann, Erin E.; Bishop, Jeffrey R.; Rubin, Leah H.; More

AIDS . 27(11):1779-1782, July 17, 2013.

Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV study

Parrinello, Christina M.; Landay, Alan L.; Hodis, Howard N.; More

AIDS . 27(9):1516-1519, June 1, 2013.

Underlying genetic structure impacts the association between CYP2B6 polymorphisms and response to efavirenz and nevirapine

Frasco, Melissa A.; Mack, Wendy J.; Van Den Berg, David; More

AIDS . 26(16):2097-2106, October 23, 2012.

The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women

Keating, Sheila M.; Golub, Elizabeth T.; Nowicki, Marek; More

AIDS . 25(15):1823-1832, September 24, 2011.

Protease inhibitor levels in hair strongly predict virologic response to treatment

Gandhi, Monica; Ameli, Niloufar; Bacchetti, Peter; More

AIDS . 23(4):471-478, February 20, 2009.

Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women

Harris, Tiffany G; Burk, Robert D; Xue, Xiaonan; More

AIDS . 21(14):1933-1941, September 2007.

Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols

Gandhi, Monica; Ameli, Niloufar; Bacchetti, Peter; More

AIDS . 19(16):1885-1896, November 4, 2005.

Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels

Grant, Linda Ahdieh; Silverberg, Michael J.; Palacio, Herminia; More

AIDS . 15(16):2101-2108, November 9, 2001.

The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women‚s interagency HIV study

Anastos, Kathryn; Kalish, Leslie A.; Hessol, Nancy; More

AIDS . 13(13):1717-1726, September 10, 1999.

1 2 3 4 5